- Abstract
- Core Tip
- Full Article (PDF)
- Full Article (WORD)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (121)
- Timeline of Article Publication Processes (7)
- Authors Evaluation (5)
- Article Quality Tracking (2)
- Reference Citation Analysis (System.Threading.Tasks.Task`1[System.Int32])
-
Full Article (HTML) (235) -
Full Article (PDF) (48) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7774)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 21, 2019 (publication date) through May 27, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Simbrunner B, Mandorfer M, Trauner M, Reiberger T. Gut-liver axis signaling in portal hypertension. World J Gastroenterol 2019; 25(39): 5897-5917 [PMID: 31660028 DOI: 10.3748/wjg.v25.i39.5897] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i39/5897.htm |
| Number | Citing Articles |
| 1 |
Lukas Hartl, Mathias Jachs, Christopher Desbalmes, Dunja Schaufler, Benedikt Simbrunner, Rafael Paternostro, Philipp Schwabl, David Josef Maria Bauer, Georg Semmler, Bernhard Scheiner, Theresa Bucsics, Ernst Eigenbauer, Rodrig Marculescu, Thomas Szekeres, Markus Peck-Radosavljevic, Stefan Kastl, Michael Trauner, Mattias Mandorfer, Thomas Reiberger. The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes. Hepatology International 2021; 15(5): 1160 doi: 10.1007/s12072-021-10203-9
|
| 2 |
Tim Vanuytsel, Jan Tack, Ricard Farre. The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.717925
|
| 3 |
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk management. Terapevticheskii arkhiv 2021; 93(8): 963 doi: 10.26442/00403660.2021.08.200917
|
| 4 |
Noemi Daradics, Pim B. Olthof, Andras Budai, Michal Heger, Thomas M. van Gulik, Andras Fulop, Attila Szijarto. The Role of Farnesoid X Receptor in Accelerated Liver Regeneration in Rats Subjected to ALPPS. Current Oncology 2021; 28(6): 5240 doi: 10.3390/curroncol28060438
|
| 5 |
Lorenz Balcar, Georg Semmler, Katharina Pomej, Benedikt Simbrunner, David Bauer, Lukas Hartl, Mathias Jachs, Rafael Paternostro, Theresa Bucsics, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Bernhard Scheiner. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure. United European Gastroenterology Journal 2021; 9(4): 427 doi: 10.1002/ueg2.12089
|
| 6 |
Shujie Xu, Qi Wang, Fei Wang, Xiang Li, Baikui Wang, Yuanhao Zhou, Peng Zou, Li Tang, Dongyou Yu, Weifen Li. Improved immune function of Chinese soft-shelled turtles (Pelodiscus sinensis) through oral probiotics via the TLR signaling pathway. Aquaculture 2022; 555: 738126 doi: 10.1016/j.aquaculture.2022.738126
|
| 7 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Anna Kudryavtseva, George Krasnov. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World Journal of Gastroenterology 2022; 28(10): 1067-1077 doi: 10.3748/wjg.v28.i10.1067
Abstract(73) |
Core Tip(64) |
Full Article(HTML)(483)
|
Full Article (PDF)-2025K(71)
|
Full Article (Word)-316K(15)
|
Audio-1916K(8)
|
Peer-Review Report-256K(8)
|
Answering Reviewers-230K(14)
|
Times Cited (0)
|
Total Visits (1379)
|
Open
|
| 8 |
Alix Bruneau, Jana Hundertmark, Adrien Guillot, Frank Tacke. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725390
|
| 9 |
Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, David J. M. Bauer, Georg Semmler, Daniela Gompelmann, Thomas Szekeres, Peter Quehenberger, Michael Trauner, Mattias Mandorfer, Bernhard Scheiner, Thomas Reiberger. Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19. Journal of Personalized Medicine 2021; 11(12): 1264 doi: 10.3390/jpm11121264
|
| 10 |
Dalila Costa, Benedikt Simbrunner, Mathias Jachs, Lukas Hartl, David Bauer, Rafael Paternostro, Philipp Schwabl, Bernhard Scheiner, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. Journal of Hepatology 2021; 74(4): 819 doi: 10.1016/j.jhep.2020.10.004
|
| 11 |
Jeanne A. Ishimwe, Thanvi Dola, Lale A. Ertuglu, Annet Kirabo. Bile acids and salt-sensitive hypertension: a role of the gut-liver axis. American Journal of Physiology-Heart and Circulatory Physiology 2022; 322(4): H636 doi: 10.1152/ajpheart.00027.2022
|
| 12 |
Benedikt Simbrunner, Michael Trauner, Thomas Reiberger. Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis. Alimentary Pharmacology & Therapeutics 2021; 54(10): 1243 doi: 10.1111/apt.16602
|
| 13 |
Mathias Jachs, Lukas Hartl, Dunja Schaufler, Christopher Desbalmes, Benedikt Simbrunner, Ernst Eigenbauer, David Josef Maria Bauer, Rafael Paternostro, Philipp Schwabl, Bernhard Scheiner, Theresa Bucsics, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut 2021; 70(9): 1758 doi: 10.1136/gutjnl-2020-322712
|
| 14 |
Chunxia Yu, Sujuan Liu, Yanmei Niu, Li Fu. Exercise protects intestinal epithelial barrier from high fat diet- induced permeabilization through SESN2/AMPKα1/HIF-1α signaling. The Journal of Nutritional Biochemistry 2022; : 109059 doi: 10.1016/j.jnutbio.2022.109059
|
| 15 |
Radmila V Karpova, Ksenia S Russkova, Yuliya N Lavrentieva. <p>Increases in Autoantibody Level Associated with Degenerative Changes in the Intestinal Mucosa in Liver Cirrhosis</p>. Clinical and Experimental Gastroenterology 2020; : 315 doi: 10.2147/CEG.S263176
|
| 16 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Probiotics in hepatology: An update. World Journal of Hepatology 2021; 13(9): 1154-1166 doi: 10.4254/wjh.v13.i9.1154
|
| 17 |
Pierre Raeven, Joanna Baron-Stefaniak, Benedikt Simbrunner, Alexander Stadlmann, Philipp Schwabl, Bernhard Scheiner, Eva Schaden, Ernst Eigenbauer, Peter Quehenberger, Mattias Mandorfer, David Marek Baron, Thomas Reiberger. Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension. Hepatology International 2020; 14(6): 1083 doi: 10.1007/s12072-020-10093-3
|
| 18 |
Tingshuai Wang, Shaodong Huang, Cong Wu, Na Wang, Rongzhen Zhang, Minggang Wang, Dewen Mao, Célia Cabral. Intestinal Microbiota and Liver Diseases: Insights into Therapeutic Use of Traditional Chinese Medicine. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6682581
|
| 19 |
Mattias Mandorfer, Virginia Hernández-Gea, Juan Carlos García-Pagán, Thomas Reiberger. Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review. Seminars in Liver Disease 2020; 40(03): 240 doi: 10.1055/s-0040-1708806
|
| 20 |
Katharina Pomej, Lorenz Balcar, Bernhard Scheiner, Georg Semmler, Tobias Meischl, Mattias Mandorfer, Thomas Reiberger, Christian Müller, Michael Trauner, Matthias Pinter. Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Journal of Hepatocellular Carcinoma 2021; : 1485 doi: 10.2147/JHC.S317957
|
| 21 |
Hiroki Nishikawa, Hirayuki Enomoto, Shuhei Nishiguchi, Hiroko Iijima. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis. International Journal of Molecular Sciences 2020; 21(15): 5254 doi: 10.3390/ijms21155254
|
| 22 |
Georg Semmler, Mattias Mandorfer. Nachbetreuung von PatientInnen mit „sustained virologic response“. Journal für Gastroenterologische und Hepatologische Erkrankungen 2020; 18(4): 110 doi: 10.1007/s41971-020-00087-1
|
| 23 |
Alexander Queck, Frank E. Uschner, Philip G. Ferstl, Martin Schulz, Maximilian J. Brol, Michael Praktiknjo, Robert Schierwagen, Sabine Klein, Christian P. Strassburg, Carsten Meyer, Christian Jansen, Marie-Luise Berres, Jonel Trebicka, Pavel Strnad. Role of circulating angiogenin levels in portal hypertension and TIPS. PLOS ONE 2021; 16(8): e0256473 doi: 10.1371/journal.pone.0256473
|
| 24 |
Yan-Jiao Wang, Ya-Bi Zhu, Wen-Jia Wei. Effect of non-selective β-receptor blockers on inflammatory factors and prognosis in advanced chronic liver disease. World Chinese Journal of Digestology 2021; 29(19): 1110 doi: 10.11569/wcjd.v29.i19.1110
|
| 25 |
Rémy Schwarzer, Thomas Reiberger, Mattias Mandorfer, Danijel Kivaranovic, Silvia Hametner, Stephanie Hametner, Rafael Paternostro, Bernhard Scheiner, Jenifer Schneeweiss-Friedl, Michael Trauner, Rainer Schoefl, Andreas Maieron. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis. Journal of Gastroenterology 2020; 55(5): 533 doi: 10.1007/s00535-019-01656-9
|
| 26 |
Ying-Zi Qi, Yue-Hua Jiang, Ling-Yu Jiang, Lin-Lin Shao, Xue-Song Yang, Chuan-Hua Yang. An Insight Into Intestinal Microbiota of Spontaneously Hypertensive Rats After Valsartan Administration. Dose-Response 2021; 19(2): 155932582110113 doi: 10.1177/15593258211011342
|
| 27 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Aliya Alieva, Ekaterina Kashuh, Ekaterina Tsvetaeva, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis. World Journal of Hepatology 2021; 13(5): 557-570 doi: 10.4254/wjh.v13.i5.557
|
| 28 |
|
| 29 |
Rachel M. Golonka, Johnathan Kawika Cooper, Rochell Issa, Pratyush Pavan Devarasetty, Veda Gokula, Joshua Busken, Jasenka Zubcevic, Jennifer Hill, Matam Vijay-Kumar, Bindu Menon, Bina Joe. Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis. Current Hypertension Reports 2021; 23(5) doi: 10.1007/s11906-021-01142-9
|
| 30 |
Thit Mynster Kronborg, Henriette Ytting, Lise Hobolth, Søren Møller, Nina Kimer. Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.718896
|
| 31 |
Søren Møller, Nina Kimer, Mads Barløse, Flemming Bendtsen. Pathophysiological-based treatments of complications of cirrhosis. Scandinavian Journal of Gastroenterology 2020; 55(4): 383 doi: 10.1080/00365521.2020.1744709
|
| 32 |
Mattias Mandorfer, Benedikt Simbrunner. Prevention of First Decompensation in Advanced Chronic Liver Disease. Clinics in Liver Disease 2021; 25(2): 291 doi: 10.1016/j.cld.2021.01.003
|
| 33 |
Zefeng Chen, Jingsheng Ruan, Dinghua Li, Min Wang, Zhiwei Han, Wenxia Qiu, Guobin Wu. The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy. Frontiers in Cellular and Infection Microbiology 2021; 10 doi: 10.3389/fcimb.2020.595759
|